Immunotherapy

Identifier: CI-DRUG-00000300
Entity page: /drug/immunotherapy ↗
Edges: 153

Neighbours: 17 cancers3 variants10 trials
Drawn: 30 of 30 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Immunotherapy predicts response to …PREDICTS_RESPONSE_TO3 of 3
← predicts response to	High	sensitivity	B	Urothelial Carcinoma	1	Curated	civic	graph →
← predicts response to	KMT2A Mutationother	sensitivity	B

Immunotherapy investigated for …INVESTIGATED_FOR2 of 2
→ investigated for	Urothelial Carcinomasubtype	supports	B	Urothelial Carcinoma	1	Curated	civic	graph →
→ investigated for	Malignant Neoplasmcancer_family	supports	B	Malignant Neoplasm	1	Curated	civic	graph →

Immunotherapy investigated for …INVESTIGATED_FOR2 of 2

→ investigated for

Urothelial Carcinomasubtype

supports

Urothelial Carcinoma

Curated

Immunotherapy investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 54show all (up to 200)
→ investigated in trials for	Lung Non-Small Cell Carcinoma 27 trials (9 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lung Non-Small Cell Carcinoma	27	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Lung Neoplasm 8 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Lung Neoplasm	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Melanoma 8 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Melanoma	8	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Esophageal Neoplasm 6 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Esophageal Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Colorectal Neoplasm 5 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Colorectal Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Solid Neoplasm 5 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Solid Neoplasm	5	Observed	clinicaltrials	graph →
→ investigated in trials for	Esophageal Squamous Cell Carcinoma 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Esophageal Squamous Cell Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Lung Small Cell Carcinoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lung Small Cell Carcinoma	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Head and Neck Neoplasm 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Head and Neck Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Rectal Neoplasm 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Rectal Neoplasm	3	Observed	clinicaltrials	graph →
→ investigated in trials for	Esophageal Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Esophageal Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Esophageal Neoplasm 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Esophageal Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Hepatocellular Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Hepatocellular Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Lymphoma 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Lymphoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Malignant Breast Neoplasm 2 trials (0 active) · conditions mapped to this cancer only (no hierarchy roll-up)	—	—	Malignant Breast Neoplasm	2	Observed	clinicaltrials	graph →

Immunotherapy studied in …STUDIED_INderived10 of 94show all (up to 200)
→ studied in	NCT04638751suspended ARGONAUT: Stool and Blood Sample Bank for Cancer Patients · 94 trials list this drug (54 active)	—	—	Lung Non-Small Cell Carcinoma,Pancreatic Carcinoma,Malignant Colorectal Neoplasm+1	1	Observed	clinicaltrials	graph →
→ studied in	NCT05863052active not recruiting Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population · 94 trials list this drug (54 active)	—	—	Solid Neoplasm,Malignant Digestive System Neoplasm,Melanoma+2	1	Observed	clinicaltrials	graph →
→ studied in	NCT07000253Phase 2 · recruiting Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma · 94 trials list this drug (54 active)	—	—	Malignant Esophageal Neoplasm,Childhood Gastric Carcinoma,Esophageal Carcinoma+1	1	Observed	clinicaltrials	graph →
→ studied in	NCT07062055Phase 2 · recruiting BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or Oligometastases · 94 trials list this drug (54 active)	—	—	Hepatocellular Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07691645Phase 2 · not yet recruiting Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome · 94 trials list this drug (54 active)	—	—	not mapped	1	Observed	clinicaltrials	graph →
→ studied in	NCT04151940NA · recruiting PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer · 94 trials list this drug (54 active)	—	—	Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06410300recruiting Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy · 94 trials list this drug (54 active)	—	—	Malignant Lung Neoplasm	1	Observed	clinicaltrials	graph →
→ studied in	NCT06627595recruiting Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management · 94 trials list this drug (54 active)	—	—	Melanoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06974110Phase 1 · recruiting Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors · 94 trials list this drug (54 active)	—	—	Solid Neoplasm,Malignant Gastric Neoplasm,Malignant Colorectal Neoplasm+1	1	Observed	clinicaltrials	graph →
→ studied in	NCT06130826Phase 1 · recruiting Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer · 94 trials list this drug (54 active)	—	—	Breast Carcinoma,Colorectal Carcinoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Paths